LUMINITA DUMITRU: Open Payments
NPI 1972808244 · BARNESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 35 payments from 10 companies in 2025. Trend: 2023 $37 · 2024 $381 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $877 |
| Amgen Inc. | 9 | $229 |
| ABBVIE INC. | 4 | $176 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $169 |
| Novartis Pharmaceuticals Corporation | 5 | $98 |
| Cycle Pharmaceuticals Inc | 1 | $26 |
| Novo Nordisk Inc | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, XIFAXAN, REPATHA, QULIPTA, LEQVIO, OTEZLA, UBRELVY.
Industry payments across GA — which companies pay providers there.
